NCT04978961 is a NA clinical trial of Focused Acceptance & Commitment Therapy (FACT) in Chronic Pain, sponsored by The University of Texas Health Science Center at San Antonio.

Who is sponsoring NCT04978961?

NCT04978961 is sponsored by The University of Texas Health Science Center at San Antonio.

What drugs are being tested in NCT04978961?

Interventions in NCT04978961: Focused Acceptance & Commitment Therapy (FACT), Enhanced Treatment as Usual (ETAU).

What condition does NCT04978961 study?

NCT04978961 studies Chronic Pain.

Is NCT04978961 still recruiting?

NCT04978961 is currently completed. Last updated 27 July 2021.

Last reviewed 2021-07-27 · How we verify

NCT04978961

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Acceptance and Commitment Therapy for Chronic Pain in Integrated Primary Care

Completed NA Last updated 27 July 2021

What this trial tests

NA trial testing Focused Acceptance & Commitment Therapy (FACT) in Chronic Pain in 26 participants. Completed in 22 April 2019.

Timeline

9 October 2017

Primary endpoint
10 December 2018

22 April 2019

Quick facts

Lead sponsor	The University of Texas Health Science Center at San Antonio
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	26
Start date	9 October 2017
Primary completion	10 December 2018
Estimated completion	22 April 2019
Sites	1 location across United States

Drugs / interventions tested

Focused Acceptance & Commitment Therapy (FACT)
Enhanced Treatment as Usual (ETAU)

Conditions studied

Chronic Pain — all drugs for Chronic Pain →

Sponsor

The University of Texas Health Science Center at San Antonio

Who can join

Adults 18 to 99, any sex, with Chronic Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This mixed-methods pilot randomized controlled trial sought to: 1) evaluate implementation of a brief Acceptance and Commitment Therapy treatment for chronic pain delivered by an integrated behavioral health consultant in primary care; and to 2) explore treatment outcomes and their associated mechanisms of change.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Addressing chronic pain with Focused Acceptance and Commitment Therapy in integrated primary care: findings from a mixed methods pilot randomized controlled trial.
Kanzler KE, Robinson PJ, McGeary DD, Mintz J, et al · · 2022 · cited 18× · PMID 35421949 · DOI 10.1186/s12875-022-01690-2

Verify or expand the search:

Other recruiting trials for Chronic Pain

Currently open trials in the same condition.

NCT07491549 — The Effect of Pain Education Group Therapy and Its Impact on Chronic Pain, Kinesiophobia, and Physical Activity · NA · recruiting
NCT07425691 — SPACE for Youth With Chronic Pain · recruiting
NCT07103135 — Optimizing Accelerated TMS for Chronic Pain With Thompson Sampling · Phase 1 · recruiting
NCT06219408 — CIH Stepped Care for Co-occurring Chronic Pain and PTSD · NA · recruiting
NCT07270406 — Healthy Behaviors for Insomnia Prevention in People With HIV and Ongoing Pain · NA · recruiting

Other The University of Texas Health Science Center at San Antonio trials

Trials by the same sponsor.

NCT07280897 — SCIPI Implementation and Evaluation: A Multi-site Proof-of-Concept Pilot Trial · NA · not yet recruiting
NCT07053319 — SGLT2i, Pioglitazone, and Ketone Production in T2D · Phase 1 · recruiting
NCT07056699 — SGLT2i, Pioglitazone, and Ketone Production in T1D · Phase 3 · not yet recruiting
NCT06609343 — Bupropion for Fatigue in End-stage Kidney Disease Patients on Hemodialysis · Phase 1, PHASE2 · not yet recruiting
NCT07437053 — Sarcopenia in Chronic Kidney Disease (CKD) Patients · EARLY_PHASE1 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04978961 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The University of Texas Health Science Center at San Antonio
Last refreshed: 27 July 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04978961.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing